Restricted accessResearch articleFirst published online 2015-07
Positively Charged Oligo[Poly(Ethylene Glycol) Fumarate] Scaffold Implantation Results in a Permissive Lesion Environment after Spinal Cord Injury in Rat
Positively charged oligo[poly(ethylene glycol) fumarate] (OPF+) scaffolds loaded with Schwann cells bridge spinal cord injury (SCI) lesions and support axonal regeneration in rat. The regeneration achieved is not sufficient for inducing functional recovery. Attempts to increase regeneration would benefit from understanding the effects of the scaffold and transplanted cells on lesion environment. We conducted morphometric and stereological analysis of lesions in rats implanted with OPF+ scaffolds with or without loaded Schwann cells 1, 2, 3, 4, and 8 weeks after thoracic spinal cord transection. No differences were found in collagen scarring, cyst formation, astrocyte reactivity, myelin debris, or chondroitin sulfate proteoglycan (CSPG) accumulation. However, when scaffold-implanted animals were compared with animals with transection injuries only, these barriers to regeneration were significantly reduced, accompanied by increased activated macrophages/microglia. This distinctive and regeneration permissive tissue reaction to scaffold implantation was independent of Schwann cell transplantation. Although the tissue reaction was beneficial in the short term, we observed a chronic fibrotic host response, resulting in scaffolds surrounded by collagen at 8 weeks. This study demonstrates that an appropriate biomaterial scaffold improves the environment for regeneration. Future targeting of the host fibrotic response may allow increased axonal regeneration and functional recovery.
SilverJ., and MillerJ.H.Regeneration beyond the glial scar. Nat Rev Neurosci, 5, 146, 2004.
3.
DavalosD., GrutzendlerJ., YangG., KimJ.V., ZuoY., JungS., LittmanD.R., DustinM.L., and GanW.B.ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci, 8, 752, 2005.
4.
StenceN., WaiteM., and DaileyM.E.Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices. Glia, 33, 256, 2001.
5.
DibajP., NadrignyF., SteffensH., SchellerA., HirrlingerJ., SchomburgE.D., NeuschC., and KirchhoffF.NO mediates microglial response to acute spinal cord injury under ATP control in vivo. Glia, 58, 1133, 2010.
6.
BartholdiD., and SchwabM.E.Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci, 9, 1422, 1997.
7.
ChenM.S., HuberA.B., van der HaarM.E., FrankM., SchnellL., SpillmannA.A., ChristF., and SchwabM.E.Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature, 403, 434, 2000.
8.
McKerracherL., DavidS., JacksonD.L., KottisV., DunnR.J., and BraunP.E.Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron, 13, 805, 1994.
9.
MukhopadhyayG., DohertyP., WalshF.S., CrockerP.R., and FilbinM.T.A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron, 13, 757, 1994.
10.
CaffertyW.B., DuffyP., HuebnerE., and StrittmatterS.M.MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci, 30, 6825, 2010.
11.
ImaiM., WatanabeM., SuyamaK., OsadaT., SakaiD., KawadaH., MatsumaeM., and MochidaJ.Delayed accumulation of activated macrophages and inhibition of remyelination after spinal cord injury in an adult rodent model. J Neurosurg Spine, 8, 58, 2008.
12.
GreenhalghA.D., and DavidS.Differences in the phagocytic response of microglia and peripheral macrophages after spinal cord injury and its effects on cell death. J Neurosci, 34, 6316, 2014.
13.
HuR., ZhouJ., LuoC., LinJ., WangX., LiX., BianX., LiY., WanQ., YuY., and FengH.Glial scar and neuroregeneration: histological, functional, and magnetic resonance imaging analysis in chronic spinal cord injury. J Neurosurg Spine, 13, 169, 2010.
14.
BushT.G., PuvanachandraN., HornerC.H., PolitoA., OstenfeldT., SvendsenC.N., MuckeL., JohnsonM.H., and SofroniewM.V.Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron, 23, 297, 1999.
15.
McKeonR.J., HokeA., and SilverJ.Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp Neurol, 136, 32, 1995.
16.
McKeonR.J., SchreiberR.C., RudgeJ.S., and SilverJ.Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J Neurosci, 11, 3398, 1991.
17.
RudgeJ.S., and SilverJ.Inhibition of neurite outgrowth on astroglial scars in vitro. J Neurosci, 10, 3594, 1990.
18.
GoritzC., DiasD.O., TomilinN., BarbacidM., ShupliakovO., and FrisenJ.A pericyte origin of spinal cord scar tissue. Science, 333, 238, 2011.
19.
TangX., DaviesJ.E., and DaviesS.J.Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res, 71, 427, 2003.
20.
De WinterF., OudegaM., LankhorstA.J., HamersF.P., BlitsB., RuitenbergM.J., PasterkampR.J., GispenW.H., and VerhaagenJ.Injury-induced class 3 semaphorin expression in the rat spinal cord. Exp Neurol, 175, 61, 2002.
21.
SoderblomC., LuoX., BlumenthalE., BrayE., LyapichevK., RamosJ., KrishnanV., Lai-HsuC., ParkK.K., TsoulfasP., and LeeJ.K.Perivascular fibroblasts form the fibrotic scar after contusive spinal cord injury. J Neurosci, 33, 13882, 2013.
22.
LindholmD., CastrenE., KieferR., ZafraF., and ThoenenH.Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J Cell Biol, 117, 395, 1992.
23.
LoganA., GreenJ., HunterA., JacksonR., and BerryM.Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2. Eur J Neurosci, 11, 2367, 1999.
24.
ShiQ., GaoW., HanX., ZhuX., SunJ., XieF., HouX., YangH., DaiJ., and ChenL.Collagen scaffolds modified with collagen-binding bFGF promotes the neural regeneration in a rat hemisected spinal cord injury model. Sci China Life Sci, 57, 232, 2014.
25.
SilvaN.A., SalgadoA.J., SousaR.A., OliveiraJ.T., PedroA.J., Leite-AlmeidaH., CerqueiraR., AlmeidaA., MastronardiF., ManoJ.F., NevesN.M., SousaN., and ReisR.L.Development and characterization of a novel hybrid tissue engineering-based scaffold for spinal cord injury repair. Tissue Eng Part A, 16, 45, 2010.
26.
JainA., KimY.T., McKeonR.J., and BellamkondaR.V.In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. Biomaterials, 27, 497, 2006.
27.
De LaporteL., YanA.L., and SheaL.D.Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury. Biomaterials, 30, 2361, 2009.
28.
PerticiV., TrimailleT., LaurinJ., FelixM.S., MarquesteT., PettmannB., ChauvinJ.P., GigmesD., and DecherchiP. Repair of the injured spinal cord by implantation of a synthetic degradable block copolymer in rat. Biomaterials, 2014.
29.
Petter-PuchnerA.H., FroetscherW., Krametter-FroetscherR., LorinsonD., RedlH., and van GriensvenM.The long-term neurocompatibility of human fibrin sealant and equine collagen as biomatrices in experimental spinal cord injury. Exp Toxicol Pathol, 58, 237, 2007.
30.
MotheA.J., TamR.Y., ZahirT., TatorC.H., and ShoichetM.S.Repair of the injured spinal cord by transplantation of neural stem cells in a hyaluronan-based hydrogel. Biomaterials, 34, 3775, 2013.
31.
RitfeldG.J., RauckB.M., NovosatT.L., ParkD., PatelP., RoosR.A., WangY., and OudegaM.The effect of a polyurethane-based reverse thermal gel on bone marrow stromal cell transplant survival and spinal cord repair. Biomaterials, 35, 1924, 2014.
32.
RungeM.B., DadsetanM., BaltrusaitisJ., RuesinkT., LuL., WindebankA.J., and YaszemskiM.J.Development of electrically conductive oligo(polyethylene glycol) fumarate-polypyrrole hydrogels for nerve regeneration. Biomacromolecules, 11, 2845, 2010.
33.
KimJ., DadsetanM., AmeenuddinS., WindebankA.J., YaszemskiM.J., and LuL.In vivo biodegradation and biocompatibility of PEG/sebacic acid-based hydrogels using a cage implant system. J Biomed Mater Res A, 95, 191, 2010.
34.
KrychA.J., RooneyG.E., ChenB., SchermerhornT.C., AmeenuddinS., GrossL., MooreM.J., CurrierB.L., SpinnerR.J., FriedmanJ.A., YaszemskiM.J., and WindebankA.J.Relationship between scaffold channel diameter and number of regenerating axons in the transected rat spinal cord. Acta Biomater, 5, 2551, 2009.
35.
DadsetanM., KnightA.M., LuL., WindebankA.J., and YaszemskiM.J.Stimulation of neurite outgrowth using positively charged hydrogels. Biomaterials, 30, 3874, 2009.
36.
ChenB.K., KnightA.M., de RuiterG.C., SpinnerR.J., YaszemskiM.J., CurrierB.L., and WindebankA.J.Axon regeneration through scaffold into distal spinal cord after transection. J Neurotrauma, 26, 1759, 2009.
37.
OlsonH.E., RooneyG.E., GrossL., NesbittJ.J., GalvinK.E., KnightA., ChenB., YaszemskiM.J., and WindebankA.J.Neural stem cell- and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng Part A, 15, 1797, 2009.
38.
de RuiterG.C., OnyenehoI.A., LiangE.T., MooreM.J., KnightA.M., MalessyM.J., SpinnerR.J., LuL., CurrierB.L., YaszemskiM.J., and WindebankA.J.Methods for in vitro characterization of multichannel nerve tubes. J Biomed Mater Res A, 84, 643, 2008.
39.
JabbariE., WangS., LuL., GruetzmacherJ.A., AmeenuddinS., HefferanT.E., CurrierB.L., WindebankA.J., and YaszemskiM.J.Synthesis, material properties, and biocompatibility of a novel self-cross-linkable poly(caprolactone fumarate) as an injectable tissue engineering scaffold. Biomacromolecules, 6, 2503, 2005.
FriedmanJ.A., WindebankA.J., MooreM.J., SpinnerR.J., CurrierB.L., and YaszemskiM.J.Biodegradable polymer grafts for surgical repair of the injured spinal cord. Neurosurgery, 51, 742, 2002.
42.
RooneyG.E., KnightA.M., MadiganN.N., GrossL., ChenB., GiraldoC.V., SeoS., NesbittJ.J., DadsetanM., YaszemskiM.J., and WindebankA.J.Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels. Tissue Eng Part A, 17, 1287, 2011.
43.
RooneyG.E., VaishyaS., AmeenuddinS., CurrierB.L., SchieferT.K., KnightA., ChenB., MishraP.K., SpinnerR.J., MacuraS.I., YaszemskiM.J., and WindebankA.J.Rigid fixation of the spinal column improves scaffold alignment and prevents scoliosis in the transected rat spinal cord. Spine, 33, E914, 2008.
44.
DalyW.T., KnightA.M., WangH., de BoerR., GiustiG., DadsetanM., SpinnerR.J., YaszemskiM.J., and WindebankA.J.Comparison and characterization of multiple biomaterial conduits for peripheral nerve repair. Biomaterials, 34, 8630, 2013.
45.
ChenB.K., KnightA.M., MadiganN.N., GrossL., DadsetanM., NesbittJ.J., RooneyG.E., CurrierB.L., YaszemskiM.J., SpinnerR.J., and WindebankA.J.Comparison of polymer scaffolds in rat spinal cord: a step toward quantitative assessment of combinatorial approaches to spinal cord repair. Biomaterials, 32, 8077, 2011.
46.
AndersonJ.M., RodriguezA., and ChangD.T.Foreign body reaction to biomaterials. Semin Immunol, 20, 86, 2008.
47.
BrownB.N., RatnerB.D., GoodmanS.B., AmarS., and BadylakS.F.Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials, 33, 3792, 2012.
48.
FranzS., RammeltS., ScharnweberD., and SimonJ.C.Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials. Biomaterials, 32, 6692, 2011.
49.
ShechterR., MillerO., YovelG., RosenzweigN., LondonA., RuckhJ., KimK.W., KleinE., KalchenkoV., BendelP., LiraS.A., JungS., and SchwartzM.Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity, 38, 555, 2013.
50.
KigerlK.A., GenselJ.C., AnkenyD.P., AlexanderJ.K., DonnellyD.J., and PopovichP.G.Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci, 29, 13435, 2009.
51.
RapalinoO., Lazarov-SpieglerO., AgranovE., VelanG.J., YolesE., FraidakisM., SolomonA., GepsteinR., KatzA., BelkinM., HadaniM., and SchwartzM.Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med, 4, 814, 1998.
52.
ShechterR., LondonA., VarolC., RaposoC., CusimanoM., YovelG., RollsA., MackM., PluchinoS., MartinoG., JungS., and SchwartzM.Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med, 6, e1000113, 2009.
53.
YinY., HenzlM.T., LorberB., NakazawaT., ThomasT.T., JiangF., LangerR., and BenowitzL.I.Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat Neurosci, 9, 843, 2006.
54.
AndersonJ.M., and JonesJ.A.Phenotypic dichotomies in the foreign body reaction. Biomaterials, 28, 5114, 2007.
55.
GaudetA.D., PopovichP.G., and RamerM.S.Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation, 8, 110, 2011.
56.
RotshenkerS.Wallerian degeneration: the innate-immune response to traumatic nerve injury. J Neuroinflammation, 8, 109, 2011.
57.
DadsetanM., SzatkowskiJ.P., YaszemskiM.J., and LuL.Characterization of photo-cross-linked oligo[poly(ethylene glycol) fumarate] hydrogels for cartilage tissue engineering. Biomacromolecules, 8, 1702, 2007.
58.
DadsetanM., LiuZ., PumbergerM., GiraldoC.V., RuesinkT., LuL., and YaszemskiM.J.A stimuli-responsive hydrogel for doxorubicin delivery. Biomaterials, 31, 8051, 2010.
59.
ShinH., Quinten RuhéP., MikosA.G., and JansenJ.A.In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. Biomaterials, 24, 3201, 2003.
60.
JoS., ShinH., ShungA.K., FisherJ.P., and MikosA.G.Synthesis and characterization of oligo(poly(ethylene glycol) fumarate) macromer. Macromolecules, 34, 2839, 2001.
61.
KinardL.A., KasperF.K., and MikosA.G.Synthesis of oligo(poly(ethylene glycol) fumarate). Nature protocols, 7, 1219, 2012.
62.
DadsetanM., PumbergerM., CasperM.E., ShogrenK., GiulianiM., RuesinkT., HefferanT.E., CurrierB.L., and YaszemskiM.J.The effects of fixed electrical charge on chondrocyte behavior. Acta biomaterialia, 7, 2080, 2011.
63.
RooneyG.E., MoranC., McMahonS.S., RitterT., MaenzM., FlugelA., DockeryP., O'BrienT., HowardL., WindebankA.J., and BarryF.P.Gene-modified mesenchymal stem cells express functionally active nerve growth factor on an engineered poly lactic glycolic acid (PLGA) substrate. Tissue Eng Part A, 14, 681, 2008.
64.
KettenmannH., HanischU.K., NodaM., and VerkhratskyA.Physiology of microglia. Physiol Rev, 91, 461, 2011.
65.
KawanoH., Kimura-KurodaJ., KomutaY., YoshiokaN., LiH.P., KawamuraK., LiY., and RaismanG.Role of the lesion scar in the response to damage and repair of the central nervous system. Cell Tissue Res, 349, 169, 2012.
66.
KlapkaN., and MullerH.W.Collagen matrix in spinal cord injury. J Neurotrauma, 23, 422, 2006.
67.
ImaiY., and KohsakaS.Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia, 40, 164, 2002.
68.
CalderonT.M., EugeninE.A., LopezL., KumarS.S., HesselgesserJ., RaineC.S., and BermanJ.W.A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J Neuroimmunol, 177, 27, 2006.
69.
SouthS.A., DeiblerG.E., TzengS.F., BadacheA., KirchnerM.G., MujaN., and De VriesG.H.Myelin basic protein (MBP) and MBP peptides are mitogens for cultured astrocytes. Glia, 29, 81, 2000.
70.
BartneckM., HeffelsK.H., PanY., BoviM., Zwadlo-KlarwasserG., and GrollJ.Inducing healing-like human primary macrophage phenotypes by 3D hydrogel coated nanofibres. Biomaterials, 33, 4136, 2012.
71.
LinkerR.A., and GoldR.Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects. Current neurology and neuroscience reports, 13, 394, 2013.
72.
AlbrechtP., BouchachiaI., GoebelsN., HenkeN., HofstetterH.H., IssbernerA., KovacsZ., LewerenzJ., LisakD., MaherP., MausbergA.K., QuasthoffK., ZimmermannC., HartungH.P., and MethnerA.Effects of dimethyl fumarate on neuroprotection and immunomodulation. J Neuroinflammation, 9, 163, 2012.
73.
WierinckxA., BreveJ., MercierD., SchultzbergM., DrukarchB., and Van DamA.M.Detoxication enzyme inducers modify cytokine production in rat mixed glial cells. J Neuroimmunol, 166, 132, 2005.
74.
LinS.X., LisiL., Dello RussoC., PolakP.E., SharpA., WeinbergG., KalininS., and FeinsteinD.L.The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1. ASN Neuro, 3, 2011.
75.
WillerthS.M., and Sakiyama-ElbertS.E.Cell therapy for spinal cord regeneration. Adv Drug Deliv Rev, 60, 263, 2008.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
